Figure 1.
Effect of antidiabetic drugs on metabolic and liver outcomes in patients with non-alcoholic fatty liver disease. SGLT-2: sodium-glucose cotransporter 2; DPP-4: Dipeptidyl peptidase-4; GLP-1: Glucagon-like pepide-1.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.